Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Pharm Sci. 2014 Jun 19;103(8):2520–2529. doi: 10.1002/jps.24046

Figure 2. Concentration- and time-dependent atazanavir and darunavir release from lipid-drug nanoparticles.

Figure 2

The release of atazanavir (panel A) and darunavir (panel B) from lipid-drug nanoparticles at 5 mM (●) , 25 mM (■), and 200 mM (▲) were monitored at 25°C. Data were expressed as mean ± SD % drug release of triplicate samples.